Abstract 13 A Randomized, Placebo-Controlled, Phase II Trial of Intravenous Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke

INTRODUCTION: Stroke is the fifth leading cause of death in the United States. Tissue plasminogen activator and mechanical thrombectomy are the only effective treatments, but many patients are ineligible for these treatments. OBJECTIVE: The objective of this study was to determine whether an intrave...

Descripción completa

Detalles Bibliográficos
Autores principales: Laskowitz, Daniel, Poehlein, Emily, Schpall, Elizabeth, Willson, Jeff, Wingard, John, Freed, Brian, Belagaje, Samir, Khanna, Anna, Duarte, Daniel Vela, Volpi, John, Marrotte, Eric, Troy, Jesse, Kurtzberg, Joanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Trials – Regenerative Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446917/
http://dx.doi.org/10.1093/stcltm/szac057.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446917/
http://dx.doi.org/10.1093/stcltm/szac057.013

Ejemplares similares